Correlation Between Nutriband and Neurosense Therapeutics

Can any of the company-specific risk be diversified away by investing in both Nutriband and Neurosense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nutriband and Neurosense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nutriband and Neurosense Therapeutics, you can compare the effects of market volatilities on Nutriband and Neurosense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nutriband with a short position of Neurosense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nutriband and Neurosense Therapeutics.

Diversification Opportunities for Nutriband and Neurosense Therapeutics

0.14

Correlation Coefficient

Nutriband  Neurosense Therapeutics

Average diversification

The 3 months correlation between Nutriband and Neurosense is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Nutriband and Neurosense Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurosense Therapeutics and Nutriband is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nutriband are associated (or correlated) with Neurosense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurosense Therapeutics has no effect on the direction of Nutriband i.e., Nutriband and Neurosense Therapeutics go up and down completely randomly.

Pair Corralation between Nutriband and Neurosense Therapeutics

Given the investment horizon of 90 days Nutriband is expected to generate 0.9 times more return on investment than Neurosense Therapeutics. However, Nutriband is 1.11 times less risky than Neurosense Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Neurosense Therapeutics is currently generating about 0.03 per unit of risk. If you would invest  352.00  in Nutriband on October 3, 2024 and sell it today you would earn a total of  119.00  from holding Nutriband or generate 33.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Nutriband  vs.  Neurosense Therapeutics

Nutriband

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nutriband has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Neurosense Therapeutics

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Neurosense Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Neurosense Therapeutics may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Nutriband and Neurosense Therapeutics

The main advantage of trading using opposite Nutriband and Neurosense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nutriband position performs unexpectedly, Neurosense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurosense Therapeutics will offset losses from the drop in Neurosense Therapeutics' long position.

The idea behind Nutriband and Neurosense Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.